Biohaven Pharmaceutical (NYSE:BHVN) Insider Buying and Selling Activity
Insider Ownership Percentage: 34.20%
Biohaven Pharmaceutical (NYSE BHVN) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 3/14/2019 | Vlad Coric | CEO | Sell | 100,000 | $50.09 | $5,009,000.00 | |  |
| 3/12/2019 | John Tilton | Insider | Sell | 10,000 | $50.11 | $501,100.00 | 10,000 | |
| 3/12/2019 | Vlad Coric | CEO | Sell | 51,962 | $50.15 | $2,605,894.30 | | |
| 3/1/2019 | Declan Doogan | Director | Sell | 50,595 | $47.17 | $2,386,566.15 | 394,083 | |
| 2/27/2019 | Declan Doogan | Director | Sell | 27,045 | $45.02 | $1,217,565.90 | 394,083 | |
| 2/21/2019 | Julia P Gregory | Director | Sell | 12,000 | $43.56 | $522,720.00 | 12,000 | |
| 2/19/2019 | Declan Doogan | Director | Sell | 2,078 | $45.48 | $94,507.44 | | |
| 2/13/2019 | Declan Doogan | Director | Sell | 40,000 | $44.31 | $1,772,400.00 | | |
| 1/10/2019 | John Tilton | Insider | Sell | 10,500 | $37.67 | $395,535.00 | 10,500 | |
| 6/15/2018 | Kimberly Gentile | VP | Sell | 12,500 | $40.02 | $500,250.00 | 12,500 | |
| 6/12/2018 | Robert Berman | Insider | Sell | 104,155 | $36.33 | $3,783,951.15 | | |
| 6/7/2018 | Robert Berman | Insider | Sell | 25,845 | $36.01 | $930,678.45 | | |
| 6/5/2018 | Declan Doogan | Director | Sell | 89,216 | $35.25 | $3,144,864.00 | | |
| 6/5/2018 | Robert Berman | Insider | Sell | 6,362 | $36.02 | $229,159.24 | | |
| 6/1/2018 | Declan Doogan | Director | Sell | 110,784 | $35.03 | $3,880,763.52 | 463,913 | |
| 6/1/2018 | Vlad Coric | CEO | Sell | 50,000 | $35.02 | $1,751,000.00 | | |
| 5/30/2018 | Declan Doogan | Director | Sell | 842 | $35.00 | $29,470.00 | 463,913 | |
| 5/30/2018 | James Engelhart | CFO | Sell | 5,000 | $35.00 | $175,000.00 | 5,000 | |
| 5/30/2018 | Vlad Coric | CEO | Sell | 1,541 | $35.00 | $53,935.00 | | |
| 5/10/2018 | Robert Berman | Insider | Sell | 35,000 | $26.82 | $938,700.00 | | |
| 5/7/2018 | James Engelhart | CFO | Sell | 2,500 | $27.67 | $69,175.00 | | |
| 4/10/2018 | Robert Berman | Insider | Sell | 35,000 | $24.66 | $863,100.00 | | |
| 3/12/2018 | Robert Berman | Insider | Sell | 35,000 | $30.11 | $1,053,850.00 | | |
| 3/1/2018 | Kimberly Gentile | VP | Sell | 5,000 | $32.87 | $164,350.00 | | |
| 2/21/2018 | James Engelhart | CFO | Sell | 538 | $29.60 | $15,924.80 | 3,038 | |
| 2/12/2018 | Robert Berman | Insider | Sell | 35,000 | $30.42 | $1,064,700.00 | | |
| 2/1/2018 | Kimberly Gentile | VP | Sell | 5,000 | $32.78 | $163,900.00 | 5,000 | |
| 1/31/2018 | Gregory Bailey | Director | Sell | 50,000 | $33.71 | $1,685,500.00 | 2,516,701 | |
| 1/22/2018 | Gregory Bailey | Director | Sell | 49,000 | $30.76 | $1,507,240.00 | 2,583,289 | |
| 1/22/2018 | James Engelhart | CFO | Sell | 10,000 | $32.50 | $325,000.00 | 13,576 | |
| 1/19/2018 | Portage Biotech Inc. | Major Shareholder | Sell | 35,119 | $30.03 | $1,054,623.57 | | |
| 1/18/2018 | Declan Doogan | Director | Sell | 128,058 | $26.95 | $3,451,163.10 | 2,583,289 | |
| 1/16/2018 | Gregory Bailey | Director | Sell | 40,000 | $26.52 | $1,060,800.00 | | |
| 1/12/2018 | Declan Doogan | Director | Sell | 121,942 | $26.78 | $3,265,606.76 | | |
| 1/10/2018 | Declan Doogan | Director | Sell | 40,362 | $27.69 | $1,117,623.78 | | |
| 1/10/2018 | Robert Berman | Insider | Sell | 35,000 | $27.52 | $963,200.00 | | |
| 1/9/2018 | Portage Biotech Inc. | Major Shareholder | Sell | 84,881 | $30.06 | $2,551,522.86 | 6,278,504 | |
| 1/5/2018 | Portage Biotech Inc. | Major Shareholder | Sell | 22,996 | $30.03 | $690,569.88 | 6,278,504 | |
| 1/4/2018 | Gregory Bailey | Director | Sell | 50,000 | $28.71 | $1,435,500.00 | 1,187,275 | |
| 1/3/2018 | Portage Biotech Inc. | Major Shareholder | Sell | 35,650 | $28.61 | $1,019,946.50 | 124,371 | |
| 1/2/2018 | Kimberly Gentile | VP | Sell | 5,000 | $27.60 | $138,000.00 | 5,000 | |
| 12/20/2017 | Gregory Bailey | Director | Sell | 39,430 | $26.31 | $1,037,403.30 | 1,234,077 | |
| 12/19/2017 | Robert Berman | Insider | Sell | 10,000 | $24.10 | $241,000.00 | | |
| 12/11/2017 | Robert Berman | Insider | Sell | 25,000 | $21.28 | $532,000.00 | | |
| 12/1/2017 | Kimberly Gentile | VP | Sell | 5,000 | $21.99 | $109,950.00 | | |
| 11/30/2017 | Gregory Bailey | Director | Sell | 9,970 | $25.48 | $254,035.60 | 1,262,759 | |
| 11/27/2017 | Gregory Bailey | Director | Sell | 20,600 | $25.92 | $533,952.00 | 1,289,699 | |
| 11/24/2017 | Gregory Bailey | Director | Sell | 600 | $26.02 | $15,612.00 | 1,289,699 | |
| 11/14/2017 | Robert Berman | Insider | Sell | 160,000 | $25.76 | $4,121,600.00 | | |
| 11/10/2017 | James Engelhart | CFO | Sell | 30,538 | $26.58 | $811,700.04 | 25,176 | |
| 11/9/2017 | Robert Berman | Insider | Sell | 27,423 | $26.60 | $729,451.80 | | |
| 11/1/2017 | John Tilton | Insider | Sell | 30,000 | $29.25 | $877,500.00 | 30,000 | |
| 11/1/2017 | Kimberly Gentile | VP | Sell | 5,000 | $29.28 | $146,400.00 | 5,000 | |
| 11/1/2017 | Vlad Coric | CEO | Sell | 150,000 | $29.41 | $4,411,500.00 | | |
| 5/9/2017 | Albert Cha | Director | Buy | 470,000 | $17.00 | $7,990,000.00 | | |
| 5/9/2017 | James Engelhart | CFO | Buy | 2,500 | $17.00 | $42,500.00 | 3,576 | |
| 5/9/2017 | Robert Berman | Insider | Buy | 50 | $17.00 | $850.00 | | |
(Data available from 1/1/2013 forward)
